The aim of the present study is to construct a competitive endogenous RNA (ceRNA) regulatory network by using differentially expressed long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and mRNAs in patients with hepatocellular carcinoma (HCC), and to construct a prognostic model for predicting overall survival (OS) of HCC patients.
| INTRODUC TI ON
Hepatocellular carcinoma is the seventh most prevalent malignant tumor and the third leading cause for tumor-associated mortality. 1 It was estimated that there were 841 080 newly diagnosed HCC patients and 781 631 HCC patients died in 2018. 1 Most HCC patients were diagnosed at an advanced stage because early stage HCC patients often have no obvious clinical symptoms. Although great progress has been made in the diagnosis and treatment of HCC, the 5-year OS rate in advanced stage HCC patients is still less than 20%. 2, 3 It has been reported that the average OS of advanced stage HCC patients who did not receive systematic treatments was merely 7.1 months. 4 To date, the molecular biological mechanisms affecting the progression and prognosis of HCC have not been fully illuminated. 5 From the point of view of clinical practice, exploration of molecular biological mechanisms affecting the prognosis of HCC and identification of reliable prognostic biomarkers are valuable for optimizing individualized treatments and improving clinical prognosis.
Emerging evidence has revealed potential molecular biological mechanisms and regulatory pathways in the progression and prognosis in HCC patients. [6] [7] [8] [9] The hypothesis of ceRNA, proposed by Salmena et al, 10 depicted a specific molecular biological regulatory mechanism for posttranscriptional regulation. Long noncoding RNAs could indirectly regulate the expression of mRNAs through competitively binding response elements of miRNAs as endogenous molecular sponges. 11 Several studies have explored the molecular biological regulatory mechanisms for prognosis of HCC patients through the ceRNA regulatory network. [12] [13] [14] Lin et al 13 constructed 3 prognostic prediction models by using lncRNAs, miRNAs, and mRNAs, whereas Bai et al 15 constructed an lncRNA prognostic model for OS in HCC patients based on 13 lncRNAs identified by a ceRNA regulatory network. However, these prognostic models were limited by the following reasons: complex calculation formulas, results with unclear prognostic significance, and lack of external validation. Therefore, a prognostic model with a simple calculation formula, easily interpreted results, and reliable external repeatability is of great significance for optimizing individualized therapy.
The nomogram, as a graphical display tool, was convenient to calculate and interpret the predictive results. 16, 17 Therefore the aim of the present study is to develop and validate a prognostic nomogram for OS of HCC patients based on gene expression data identified by a ceRNA regulatory network.
| MATERIAL S AND ME THODS

| Protocol approval
All datasets in the present study were downloaded from public databases, including TCGA and the cBioPortal and GEO database. These public databases allowed researchers to download and analyze public datasets for scientific purposes and thus ethics approval was not required.
| Gene expression information of the model dataset
We downloaded the original RNA expression dataset from TCGA generated on the Illumina HiSeq 2000 RNA Sequencing platform.
The RNA symbols were determined based on GENCODE version 
| Differentially expressed analyses
The differentially expressed analyses were carried out between HCC tissues and adjacent normal liver tissues, with a defined P of .05 and a ratio of 1.5 times between tumor tissue expression and adjacent normal liver tissue expression.
| Clinical dataset of the model group
According to the medians of the original gene expression values, the original expression values were converted into "0" for lower The mean ± SD age of HCC patients in the model dataset was 59.5 ± 13.4 years. One hundred and thirty (37.4%) patients out of 348 HCC patients died within the follow-up period (mean ± SD, 843 ± 714 days).
| Validation group dataset
The validation datasets were downloaded from the GEO data- 
| Decision curve analysis
The DCA has been recommended to evaluate and compare the performance of predictive models or prognostic models. [20] [21] [22] The DCA analyses were carried out to assess the predictive performance of the prognostic nomogram. 
| Functional enrichment analyses
Gene ontology functional enrichment analyses were carried out to explore the biological significance of the prognostic mRNAs in the ceRNA network by using the "clusterProfler" package.
P < .05 was defined as the threshold of statistical significance for Fisher's test. TA B L E 2 Top 10 upregulated and downregulated differentially expressed RNAs in hepatocellular carcinoma samples prognostic indicators for OS. To compare the difference of survival curves between high-risk and low-risk groups, Kaplan-Meier survival analyses were carried out. Time-dependent ROC curves were used to assess the predictive performance of prognostic models.
| Statistical analysis
The statistical analyses were carried out through SPSS Statistics 19.0 (SPSS Inc.) and R software (version 3.5.2) with the following packages: "GOplot", "timeROC ", "rms", "pROC", "survival", "clusterProfler" and "glmnet ". P value <.05 was the threshold value for statistical significance.
| RE SULTS
| Study cohort
There were 348 HCC patients in the model group and 301 HCC patients in the validation group. In the model group, 130 patients (37.4%) died during the follow-up period; 104 patients (34.6%) died during the follow-up period in the verification group. The basic clinical features of HCC patients in the model and verification groups are shown in Table 1 .
| Differentially expressed analyses
According to the given threshold, 5035 mRNAs (3329 upregulated 
| Screening of prognostic mRNAs for OS
The univariate Cox analyses were used to screen the potential candidates for OS through TCGA clinical dataset based on previous differentially expressed mRNAs. There were 1918 differentially expressed mRNAs identified as potential prognostic mRNAs by using univariate Cox analyses.
| Construction of ceRNA network
The differentially expressed lncRNAs (n = 455), miRNAs (n = 181), and prognostic mRNAs (n = 1918) were used to construct a ceRNA network. To obtain the biological targets of lncRNAs, the miRcode database (http://www.mirco de.org/) was searched according to the differentially expressed lncRNAs (n = 455). To obtain the biological targets of miRNAs, TargetScan (http://www.targe tscan.
org/), miRDB (http://www.mirdb.org/), and miRTarBase (http:// mirta rbase.mbc.nctu.edu.tw/php/index.php) were searched according to the previous lncRNA-targeted miRNAs (n = 208). The miRNA-predicted mRNAs that could be searched in the 3 databases were defined as the miRNA-targeted mRNAs (n = 1269).
Then we undertook an interaction between miRNA-targeted mRNAs and prognostic mRNAs to gain the prognosis-associated miRNA-targeted mRNAs (n = 105). Finally, 43 lncRNAs, 37 miRNAs, and 105 mRNAs were used to build the ceRNA network for OS of HCC patients. The regulatory network and potential pathways among lncRNA-miRNA-mRNA are summarized in Table S1 .
F I G U R E 1 Differentially expressed genes and competitive endogenous RNA network chart to identify prognostic biomarkers for overall survival in hepatocellular carcinoma. Volcano plots of mRNAs (A), microRNAs (miRNAs) (B), and long noncoding RNAs (lncRNAs) (C) are shown
Cytoscape software was used to demonstrate the ceRNA network (Figure 2 ).
There were 536 connections between 43 lncRNAs and 37 miRNAs, whereas there were 169 connections between 37 miRNAs and 105 mRNAs.
| Functional enrichment analyses
Gene Ontology and KEGG analyses were carried out to explore the functions associated with the prognostic mRNAs in the ceRNA network. Figure 3 shows the barplot and the dotplot of GO terms for OS. The GO terms (Figure 4 ) and KEGG pathways ( Figure 5 ) are displayed by the "GOplot" package. The top 5 GO terms of prognostic mRNAs in the ceRNA network were mainly enriched in DNA replication, extrinsic apoptotic signaling pathway, signal transduction in absence of ligand, extrinsic apoptotic signaling pathway in absence of ligand, and regulation of apoptotic signaling pathway. The KEGG pathways of these prognostic mRNAs were mainly enriched in terms of cell cycle, focal adhesion, regulation of actin cytoskeleton, and cellular senescence.
F I G U R E 4
Chord chart of Gene Ontology (GO) terms for prognostic mRNAs for overall survival in hepatocellular carcinoma. logFC, log fold change prognostic mRNAs is shown in Table 3 . The risk score of the prognostic model could be calculated by using the following formula: 
| Distribution characteristics of prognostic model score
To display the distribution characteristics of prognostic model score, a scatter plot ( Figure 7A ) and the interaction distribution scatter plot ( Figure 7B ) are presented. F I G U R E 6 Prognostic nomogram for overall survival in patients with hepatocellular carcinoma
TA B L E 3 Model information of prognostic mRNAs in univariate and multivariable Cox regression analyses
| Associations between prognostic mRNAs and OS
Survival curves were drawn to explore the associations between prognostic mRNAs and OS with the Kaplan-Meier method (Figure 8 ).
The differences of survival curves between the high-risk group and low-risk group were evaluated by using the log-rank test. The results indicated that all 8 prognostic mRNAs were significantly related with OS (P < .05).
| Predictive performance in model dataset
According to the median value of the prognostic model score,
HCC patients in the model cohort (n = 348) were stratified into the high-risk group (n = 174) and low-risk group (n = 174). The OS rate ( Figure 9A ) in the high-risk group was significantly poorer than that in the low-risk group (P < .001). The C-indexes of the 
| External validation of prognostic model
We externally validated the predictive performance of the prognostic model using the GSE14520 and GSE76427 datasets. 
| Independence assessment for prognostic model
We carried out multivariate Cox regression analyses to assess the independence of prognostic model for OS in HCC patients. Table 4 indicated that the prognostic model and AJCC stage were independent risk factors for OS in the model dataset by multivariate Cox regression analyses. In the validation dataset, multivariate Cox regression analyses indicated that the prognostic model and AJCC stage were independent risk factors for OS. 
| Decision curve analyses
As shown in Figure 13 , the prognostic model (red line) had the higher net benefit than pathological stage (green line). The DCA indicated that the prognostic model could gain more benefit than either the dead-all-patients scheme or the dead-none-patients scheme for prediction of 1-year OS ( Figure 13A ). The clinical impact curve ( Figure 13B ) depicted the prediction of risk stratification of 1000 patients by using the resample bootstrap method.
| Subgroup analyses
Pathological stage was an important influencing factor for prognosis of HCC patients. As shown in Figure 14 , the OS rate in the high-risk group was significantly poorer than in the low-risk group for all subgroups, indicating that the prognostic model had a stable and reliable predictive performance in different pathological stage subgroups.
| Correlation analysis
We undertook a correlation analysis to explore the potential associa- 
| Exploration of survival curves in various subgroups
To further explore survival curves of previously identified prognostic genes in different gender and pathological stage subgroups, we de- 
| D ISCUSS I ON
At present, the molecular biological mechanisms and regulatory pathways affecting the progression and prognosis of HCC remain unclear.
It is important and helpful to optimize the individualized treatment by mRNA-based prognostic model was built for OS of HCC patients through a single dataset from TCGA, but did not carry out external validation. 13 Additionally, the calculation formula of this previous prognostic model was too complex for clinical utility and the results were difficult to interpret. Therefore the present study screened the prognostic mRNA biomarkers and developed a prognostic model through the model dataset from TCGA, whereas the external validation was undertaken by using an independent external validation dataset from the GEO database.
The ceRNA regulation network is a method for describing posttranscriptional gene regulation, which is helpful for us to depict and understand the complex molecular biological regulation mechanisms. A lot of potential biomarkers in the current study were found to be closely related to OS in HCC. Through the ceRNA regulatory network, the potential lncRNA-miRNA-mRNA regulatory pathways were depicted in Figure 2 and Table S1 , which might be helpful to elucidate the potential biological mechanisms and regulatory pathways for OS of HCC. The GO terms and KEGG pathways were further explored to determine the potential molecular mechanisms for OS of HCC.
It has been reported that SQSTM1 played an important role in mediation of selective phagophore recruitment, degradation, fusion with lysosome, and autophagosome formation. 23 Silencing of SQSTM1 could inhibit degradation of Q6-induced hypoxia-inducible factor 1A. 24 Decreased autophagy activity was related with tumorigenesis in different tumors. 25, 26 SQSTM1 could interact with cyclinD1 and regulate the process of cell cycle. 27 PFKP might promote cell proliferation and inhibit apoptosis in renal carcinoma.
28
TARDBP could upregulate PFKP expression through downregulating miR-520 expression. 29 The TARDBP-miR-520-PFKP axis is important for proliferation and prognosis of HCC cells. 29 ACSL4 was prominently correlated with grade and stage. 30 Sung et al 31 reported that ACSL4 was overexpressed in HCC and increased ACSL4 could promote the proliferation of HCC cells. Triacsin C, an ACSL4 inhibitor, could suppress the proliferation of Hep3B cells through inducing apoptosis. 31 Further survival analysis indicated that ACSL4 expression was an independent prognostic risk factor for OS in HCC F I G U R E 11 Performance of the prognostic model in the verification group of patients with hepatocellular carcinoma, stratified into high-risk and low-risk groups. A, Survival curves in the verification group. B, Time-dependent receiver operating characteristic (ROC) curves in the verification group. AUROC, area under the ROC curve patients. 30 There was a significant relationship between CPEB3 expression and poor prognosis in HCC patients. 32 Increased miR-107 could promote the progression of HCC through inhibiting CPEB3 expression, which was identified as a tumor suppressor in the epidermal growth factor receptor molecular regulatory pathway. 33 The results in the present study were in good agreement with the results of previous studies.
MicroRNA-23b-3p is significantly downexpressed in HCC and was helpful to screen high-risk HCC patients. 34 MicroRNA-27a-3p
can regulate tumor cell invasion and migration through dual The median of prognostic model scores was used as the cut-off value to stratify gastric cancer patients into high-risk and low-risk groups. CI, confidence interval; HR, hazard ratio. MicroRNA-20b-5p-mimic can inhibit tumorigenicity of HCT-116 cells in Balb/c mice. 37 The miR-217/MAPK1 axis is related with migration and proliferation of HCC cells. 38 These studies indicated that miRNAs play important roles in the development and prognosis of cancer, which are of great clinical significance and are necessary to further elucidate the potential mechanisms and regulatory pathways by experimental studies.
High expression of KTN1-AS1 was significantly related with poor prognosis in HCC patients. 39 By increasing the expression level of transforming growth factor-β1, MEG3 can regulate the migration, 40 The lncRNA MCM3AP-AS1 can upregulate the expression of FOXA1 by competitive combination with miR-194-5p and promotes HCC cell proliferation. 41 The lncRNA CRNDE can promote the invasive ability of HCC cell through the Wnt/β-catenin pathway. 42 The high expression of PVT1 can promote the occurrence of HCC through effecting expression level of miR-150 and HIG2. 43 These studies indicated that lncRNA plays an important role in the occurrence and development of HCC. It is necessary to undertake experimental studies to elucidate the relevant pathogenesis and biological regulatory pathways.
The current research has the following advantages. First, the prognostic nomogram is convenient to provide the individual mortality percentages at different time points. Second, a free web calculator for OS in HCC patients was developed and maintained to facilitate users to assess the individual mortality percentages at different time points. Finally, as a noninvasive predictive tool, the prognostic nomogram provides an alternative option for HCC patients who cannot tolerate or are unwilling to undergo surgery.
The current research also has the following shortcomings.
First, the current research was carried out using gene expression data generated on gene chip detection platforms, and lacks basic experimental research by using quantitative RT-PCR method and other detection methods. Second, the study data were generated on different detection platforms, affecting the repeatability of research results in different populations. Third, the predictive performance of the prognostic nomogram in the validation group was superior to that in the model group. The median survival times were 13.7 and 15.8 months (P < .001) for dead patients in the model and validation groups, respectively, whereas the median survival times were 22.9 and 52.9 months (P < .001) for living patients in the model and validation groups, respectively. The long follow-up period in the validation group might partly explain the good predictive performance of the prognostic model compared with the model group. Finally, the model and validation datasets did not contain detailed study information such as drug regimen and other postoperative treatments, which might influence the therapeutic effect and clinical prognosis.
The current study revealed potential molecular biological regulation pathways and prognostic biomarkers by using a ceRNA regulatory network. A prognostic model based on mRNAs in the ceRNA network might be of great assistance in improving the prediction of the individual mortality risk for OS in HCC patients.
F I G U R E 1 6 Association coefficient analysis heatmap between clinical variables and genes in patients with hepatocellular carcinoma. AFP, α-fetoprotein; INR, international normalized ratio; PLT, platelet count
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